US approves Novavax COVID jab after delay, adds restrictions

US health regulators have given final approval to Novavax’s COVID vaccine after an unusual delay and have placed new restrictions on the jab, the pharmaceutical company announced Monday.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup